5-Chloro-7-iodo-8-quinolinol (Iodo chlo rhydroxy quin); Deco quinate; Diiodo hydroxy quin; and Oxy quinoline sulfate
Heterocyclic compounds with nitrogen hetero-atom(s) only: > Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: > Other: > Other: > Drugs: > 5-Chloro-7-iodo-8-quinolinol (Iodo chlo rhydroxy quin); Deco quinate; Diiodo hydroxy quin; and Oxy quinoline sulfate
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 2933.49.20.00
5-Chloro-7-iodo-8-quinolinol (Iodo chlorhydroxyquin)
5-Chloro-7-iodo-8-quinolinol is a halogenated quinoline derivative with antimicrobial properties, specifically named in HTS 2933.49.20.00 as a drug. It falls under this code as a heterocyclic compound containing a quinoline ring system with nitrogen hetero-atom, used primarily in pharmaceutical applications for treating bacterial and fungal infections.
Oxyquinoline Sulfate Pharmaceutical Grade
Oxyquinoline sulfate is a quinoline-based antimicrobial agent listed under HTS 2933.49.20.00, featuring the required nitrogen heterocyclic ring structure. Used in pharmaceuticals for its bacteriostatic properties, it qualifies as a named drug in this specific tariff subcategory.
Decoquinate USP Powder
Decoquinate is a quinoline-based coccidiostat drug explicitly listed under HTS 2933.49.20.00, used in veterinary medicine to prevent coccidiosis in poultry and cattle. As a pure heterocyclic nitrogen compound with quinoline ring, it qualifies for this specific drug subcategory in Chapter 29.
Diiodohydroxyquinoline (Diodoquin)
Diiodohydroxyquinoline, also known as Diodoquin, is an anti-infective quinoline derivative specifically enumerated in HTS 2933.49.20.00. This drug contains the quinoline ring system with iodine substitutions, used for treating intestinal amebiasis and classified as a Chapter 29 pharmaceutical compound.
Iodo Chlorhydroxyquin API Bulk Powder
Bulk Active Pharmaceutical Ingredient (API) form of 5-Chloro-7-iodo-8-quinolinol, explicitly covered by HTS 2933.49.20.00 as a named quinoline drug. This pure chemical compound with nitrogen hetero-atom in quinoline structure serves as intermediate for final dosage forms in antimicrobial therapy.